Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

CX-280-202: A Phase 1B Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety of CB-280 in Patients with Cystic Fibrosis (IRB 260736)


Collapse Overview 
Collapse sponsor award id
CX


Collapse Biography 

Collapse Time 
Collapse start date
2020-08-18